Search

Research

Posaconazole is a triazole antifungal with a broad spectrum of activity against moulds including Aspergillus spp. Emerging data suggest posaconazole may be effective in the treatment of allergic bronchopulmonary aspergillosis complicating cystic fibrosis.

Portable equipment is available to enable bedside and community-led research in rural and remote communities, including Indigenous communities where children are disproportionately affected by chronic respiratory conditions.

The discoveries that have set our research apart primarily relate to the factors early in life that cause life-long respiratory problems.

The lungs represent a key interface between the body and the environment.

News & events at Walyan Respiratory Research Centre.